$ANVS.US – ranked positive on October 14th, 2022

$ANVS.US – ranked positive on October 14th, 2022

Annovis Bio Inc – (ANVS, +N, Oct 14th)

Maria-Luisa Maccecchini (CEO since 2008) bought $497,000 of stock on the 11th of October at $27.61, increasing her stake by 2%. This is her first purchase since a minor subscription for $10,000 at $6 in the January 2020 IPO.

Mark White (Non-Executive since 2016) bought $137,000 also on the 11th of October, increasing his holding by 10%, again his first purchase since a minor subscription at the IPO.

The shares have been extremely volatile since listing, hitting a peak of $132 before falling back materially on a clinical trial failure; they are still well above the original IPO price. Whilst these are small purchases relative to their holding they are notable large purchases.

We are ranking the stock  +N.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.

If you are interested in our Stocks of the Week
those services may also be useful for you

Desktop
Service

Timely data delivery customised to every user, backed by analysis tools on our internal website

Signals
Data

We rank the stocks where transactions are most likely to indicate future share price performance

Shares
Buybacks

Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top